DSGN - Design Therapeutics Inc
IEX Last Trade
4.77
0.060 1.258%
Share volume: 98,051
Last Updated: Fri 30 Aug 2024 09:59:40 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.71
0.06
1.27%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-2.86%
1 Month
-5.00%
3 Months
20.56%
6 Months
66.67%
1 Year
104.74%
2 Year
-75.75%
Key data
Stock price
$4.77
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.96 - $5.48
52 WEEK CHANGE
$0.92
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
Company detail
CEO: João Siffert
Region: US
Website: designtx.com
Employees: 62
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: designtx.com
Employees: 62
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news